Coverage
-
August 09, 2019
A Pennsylvania federal judge has given an early green light to a total of $65.8 million in settlements to end class action claims that Cephalon paid generic-drug makers to keep a cheaper version of the narcolepsy drug Provigil away from drug counters.
16 other articles on this case.
View all »